Final Programme - iuphar
Final Programme - iuphar
Final Programme - iuphar
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
FC02 Transmembrane transport: Perspectives for disease<br />
and drug discovery<br />
Tue 052 A liposomal formulation of Azithromycin for treatment of cutaneous leishmania<br />
Omid Rajabi, (Iran), P Layegh, M Khoddami, R Salari<br />
Tue 053 Small-molecule drug design targeting PICK1 using a C-terminal dopamine transporter peptide<br />
Mette Rathje, (Denmark), MV Andersen, SE Andersen, PO Heidarsson, S Erlendsson, A Bach,<br />
FM Poulsen, K Strømgaard, U Gether<br />
Tue 054 The organic solute transporter OSTα-OSTβ – a potential determinant of drug absorption<br />
Ute Schwarz, (Canada), H Meyer zu Schwabedissen, B Urquhart, R Tirona, R Kim<br />
Tue 055 TRPC3 mediates thrombin-induced astrocyte activation and upregulates its own expression in rat<br />
cortical astrocytes<br />
H Shirakawa, T Nakagawa, Shuji Kaneko, (Japan)<br />
Tue 056 Transport characteristics of caffeine in human intestinal Caco-2 cell monolayer<br />
Libuse Smetanova, (Czech Republic), V Stetinova, D Kholova, J Kvetina, J Smetana, Z Svoboda<br />
Tue 057 MDR1 gene C3435T polymorphism is associated with the risk of threatened pregnancy interruption<br />
E Sokova, I Ignatiev, A Prilutsky, Dmitry A Sychev, (Russian Federation), V Kukes<br />
Tue 058 Relaxatory effect of magnesium on mesenteric vascular beds differs from normal and streptozotocin<br />
induced diabetic rats<br />
Nepton Soltani, (Iran), F Kharazmi, M Keshavarz<br />
Tue 059 Discovery of a monoamine transporter inhibitor via high throughput molecular model docking and<br />
pharmacophore modeling<br />
Christopher Surratt, (USA), M Indarte, Y Liu, J Madura<br />
Tue 060 Na + /Ca 2+ exchanger is involved in nitric oxide-mediated apoptosis in cultured astrocytes<br />
Kazuhiro Takuma, (Japan), T Kitao, T Kawasaki, Y Inoue, A Ikehara, T Nashida, Y Ago, T Matsuda<br />
Tue 061 Evidence for a key contribution of TMEM16A protein to the calcium-activated chloride current in rat<br />
pulmonary artery smooth muscle cells<br />
Paolo Tammaro, (UK), B Manoury, A Tamuleviciute<br />
Tue 062 Grapefruit juice markedly reduces the plasma concentrations of the OATP2B1 substrate aliskiren<br />
Tuija Tapaninen, (Finland), PJ Neuvonen, M Niemi<br />
Tue 063 Drug transporters in human mammary epithelial cells<br />
Lisa Bee-Gek Tee, (Australia), TF Sim, D Williams, A Crowe, K Ilett<br />
Tue 064 Pharmacokinetic analysis of irinotecan in Oatp1b2 knockout mice<br />
Wendy Teft, (Canada), S Mansell, S Welch, R Kim<br />
Tue 065 Molecular determinants for selective recognition of antidepressants in the human serotonin and<br />
norepinephrine transporters<br />
Mette Thomsen, (Denmark), L Sørensen, J Andersen, K Strømgaard, AK Kristensen<br />
Tue 066 Effect of garlic, ginkgo and St. John’s wort on the pharmacokinetics of fexofenadine in rats<br />
Jasmina Turkanovic, (Australia), MB Ward, RW Milne<br />
Tue 067 Highly sensitive and rapid assessment of P-glycoprotein activity in Caco-2 cells<br />
Hirkazu Wakuda, (Japan), Y Tada, N Nejime, S Kagota, K Nakamura, K Umegaki, S Yamada,<br />
K Shinozuka<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 203